Gilead Sciences (NASDAQ:GILD)

Gilead Sciences (NASDAQ:GILD)


Share Price
$ 68.20
Change
1.1 (1.64 %)
Market Cap
$86,720.03 m
Proactive Investors - Run By Investors For Investors

Gilead Sciences

Gilead Sciences, Inc. is a biopharmaceutical company that discovers, develops and commercializes therapeutics. The Company sells and distributes Truvada, Viread, Emtriva, Hepsera and AmBisome in Asia, Australia, Europe, Latin America, the Middle East and New Zealand, through its commercial teams, third party distributors or partners.

EPIC: GILD
Market: NASDAQ:GILD
52-week High/Low: $79.610 / $60.320
Sector: Health Care, Equipment & Services
Market Cap: $86,720.03 m
Website: www.gilead.com
col 3
col 4
col 5
col 6

Gilead Sciences Timeline

Market Reports Including GILD

VIEW ALL

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use